The three-year contract - which is value at around $7m - will see the Swiss life sciences supply the National Institutes of Health Centre for Regenerative Medicine with clinical grade induced pluripotent stem cells made at its facility in Walkersville, Maryland in the US.
http://www.outsourcing-pharma.com/Contract-Manufacturing/Lonza-wins-7m-US-NIH-stem-cell-contract?
http://www.outsourcing-pharma.com/Contract-Manufacturing/Lonza-wins-7m-US-NIH-stem-cell-contract?
No comments:
Post a Comment